Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Embolization: Features

Review
Postpartum Hemorrhage and Placenta Accreta Spectrum: A Review
11/04/2021
A review of the epidemiology, treatment, and management of postpartum hemorrhage and placenta accreta spectrum.
A review of the epidemiology, treatment, and management of postpartum hemorrhage and placenta accreta spectrum.
A review of the epidemiology,...
11/04/2021
Vascular Disease Management
Case Report
Coil-Assisted Flow Diversion in a Ruptured Basilar Top Aneurysm Using a Neqstent Endosaccular Device: A Novel Treatment
09/09/2021
This case report presents the details of a patient with a wide-necked basilar top aneurysm, ruptured 1 month earlier, which was managed using a new endosaccular device, Neqstent.
This case report presents the details of a patient with a wide-necked basilar top aneurysm, ruptured 1 month earlier, which was managed using a new endosaccular device, Neqstent.
This case report presents the...
09/09/2021
Vascular Disease Management
Review
Review of Embolic Protection Devices in Percutaneous Peripheral Intervention
06/11/2021
This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
This review discusses the current data available for debris burden of different atherectomy devices and efficacy of infrainguinal embolic protection devices.
This review discusses the...
06/11/2021
Vascular Disease Management
Case Report
Another Femoral Pseudoaneurysm With Newer Lessons
05/03/2021
The authors describe a pseudoaneurysm in 2013 that was managed by compression of the neck of the pseudoaneurysm.
The authors describe a pseudoaneurysm in 2013 that was managed by compression of the neck of the pseudoaneurysm.
The authors describe a...
05/03/2021
Vascular Disease Management
Uterine Fibroid Embolization: A Bellweather for the Rapidly Expanding Field of “Embolic Therapy”
Videos
Uterine Fibroid Embolization: A Bellweather for the Rapidly Expanding Field of “Embolic Therapy”
04/21/2021
04/21/2021
Vascular Disease Management
Uterine Fibroid Embolization: A Bellwether for the Rapidly Expanding Field of “Embolic Therapy”
Editor's Corner
Uterine Fibroid Embolization: A Bellwether for the Rapidly Expanding Field of “Embolic Therapy”
04/19/2021
Dr. Walker comments on Dr. Daniel Rubin and colleagues’ article “Uterine Fibroid Embolization: A Review for Endovascular Trainees."
Dr. Walker comments on Dr. Daniel Rubin and colleagues’ article “Uterine Fibroid Embolization: A Review for Endovascular Trainees."
Dr. Walker comments on Dr....
04/19/2021
Vascular Disease Management
Case Report
Pandemic Brings New Urgency to Remote Patient Monitoring
10/13/2020
A new program was introduced to improve health outcomes delivers additional value in protecting those most at-risk from COVID-19.
A new program was introduced to improve health outcomes delivers additional value in protecting those most at-risk from COVID-19.
A new program was introduced to...
10/13/2020
Vascular Disease Management
Case Report
Management of Thrombotic Occlusion of the Femoropopliteal Artery and Proximal Tibial Vessels in a COVID-19 Patient Using the Auryon™ Laser
09/15/2020
COVID-19 triggers an inflammatory condition caused by the SARS-Cov-2 virus. Thrombotic events have been commonly described in patients with COVID-19 and they are responsible for a large percentage of deaths seen from this virus.
COVID-19 triggers an inflammatory condition caused by the SARS-Cov-2 virus. Thrombotic events have been commonly described in patients with COVID-19 and they are responsible for a large percentage of deaths seen from this virus.
COVID-19 triggers an...
09/15/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement